Janssen is dedicated to making INVOKAMET® XR and INVOKAMET® (canagliflozin/metformin HCl) affordable and accessible for all patients. With inclusion on hospital, managed care, and pharmacy benefit management formularies, most commercial and Medicare Part D patients are covered at the lowest branded co-pay.1
To see the best-in-class* coverage for your patients, enter your ZIP code. Your results will appear below.
*Access statuses sourced from MMIT. Data on file. Janssen Pharmaceuticals, Inc. Data as of January 30, 2018.
Reference: 1. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ.